What are the recommendations for patients with migraines with aura who are considering or undergoing Hormone Replacement Therapy (HRT)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 10, 2025 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Migraine with Aura and Hormone Replacement Therapy

Primary Recommendation

Combined hormonal contraceptives and estrogen-containing HRT are contraindicated in women with migraine with aura due to significantly increased stroke risk. 1

Understanding the Stroke Risk

The evidence is clear and consistent across multiple high-quality guidelines:

  • Women with migraine with aura have an inherently elevated risk of ischemic stroke compared to those without migraine 2, 3
  • Estrogen-containing hormonal therapy compounds this risk substantially, with odds ratios for ischemic stroke ranging from 2.08 to 16.9 in women with migraine using combined hormonal contraceptives 3
  • The Nature Reviews Neurology consensus statement explicitly states that combined hormonal contraceptives are contraindicated in women with migraine with aura regardless of any association with their menstrual cycle 1
  • One study found an odds ratio of 6.1 (95% CI 3.1-12.1) for stroke in migraine with aura patients using hormonal contraceptives, compared to only 1.8 (95% CI 1.1-2.9) in migraine without aura 3

Clinical Decision Algorithm for HRT in Migraine with Aura

Step 1: Confirm Migraine Subtype

  • If migraine WITH aura is confirmed: Estrogen-containing HRT is contraindicated 1
  • If migraine WITHOUT aura only: Estrogen-containing HRT may be considered with caution 1

Step 2: If HRT is Absolutely Necessary (Severe Menopausal Symptoms)

When vasomotor symptoms are debilitating and non-hormonal options have failed:

  • Use transdermal estradiol rather than oral estrogen - provides more stable estrogen levels and may have a more favorable cardiovascular profile 4, 5
  • Use continuous (not cyclical) dosing to avoid hormonal fluctuations that trigger migraine 4
  • Use the lowest effective physiological dose - though specific dose-response data in migraine with aura patients is lacking 4, 3
  • Add a progestogen to decrease endometrial hyperplasia risk 4
  • Counsel extensively on increased stroke risk before initiating therapy 4, 3

Step 3: Prioritize Non-Hormonal Alternatives

First-line non-hormonal options for menopausal symptoms that also benefit migraine:

  • Venlafaxine - dual benefit for vasomotor symptoms and migraine prophylaxis 4
  • Escitalopram or paroxetine - effective for both conditions 4
  • Gabapentin - reduces both hot flashes and migraine frequency 4

Additional non-pharmacological strategies:

  • Acupuncture 4
  • Vitamin E supplementation 4
  • Black cohosh 4
  • Aerobic exercise and yoga 4

Migraine Prophylaxis During Perimenopause/Menopause

Standard migraine prophylaxis should be optimized rather than relying on HRT:

First-Line Prophylactic Agents:

  • Beta-blockers: Propranolol 80-240 mg/day, metoprolol 50-100 mg twice daily, or atenolol 25-100 mg twice daily 1
  • Topiramate: 50-100 mg daily 1
  • Candesartan: 16-32 mg daily (particularly useful if hypertensive) 1

Second-Line Agents:

  • Amitriptyline: 10-100 mg at night (may also help with sleep disturbances and mood symptoms common in menopause) 1
  • Flunarizine: 5-10 mg daily where available 1

Third-Line Agents:

  • CGRP monoclonal antibodies (erenumab, fremanezumab, galcanezumab, eptinezumab) if first and second-line options fail 1
  • OnabotulinumtoxinA for chronic migraine 1

Critical Pitfalls to Avoid

  • Do not assume menopause will improve migraine - many women experience worsening during perimenopause due to hormonal fluctuations 4, 5, 6
  • Surgical menopause often worsens migraine more than natural menopause 4
  • HRT frequently worsens migraine rather than improving it, even in women without aura 4, 6
  • Do not use cyclical HRT - the hormonal fluctuations can trigger migraine attacks 4
  • Never use combined hormonal contraceptives in migraine with aura - this is an absolute contraindication 1

Special Considerations

  • Women with pure menstrual migraine WITHOUT aura may benefit from continuous combined hormonal contraceptives, but this does not apply to migraine with aura 1
  • Perimenstrual prophylaxis with NSAIDs (naproxen) or triptans (frovatriptan, naratriptan) for 5 days starting 2 days before menses can be effective for menstrually-related attacks 1
  • The increased stroke risk with HRT in migraine with aura appears dose-dependent, though specific thresholds are not well-established 4, 3

References

1
Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

2
Research

Migraine with aura.

Revue neurologique, 2021

5
Research

Migraine, hormones and the menopausal transition.

Climacteric : the journal of the International Menopause Society, 2018

6
Research

Migraine and perimenopause.

Maturitas, 2014

Related Questions

What are the considerations for estrogen therapy in a patient with migraines with aura?
What are the treatment protocols for worsening migraines in a perimenopausal woman?
Can a patient with a history (Hx) of migraines without aura be on estrogen Hormone Replacement Therapy (HRT)?
Is Hormone Replacement Therapy (HRT) safe for patients with migraines with aura?
Is there an absolute contraindication to oral contraceptive (OC) use in patients with migraines with aura?
Does etodolac have a similar effect to other NSAIDs (Non-Steroidal Anti-Inflammatory Drugs) in reducing inflammation and pain?
What is the best approach to manage full body itch in an elderly patient?
What is the management approach for a patient with hypercalcemia and osteopenia not taking supplements?
What is the best treatment for external hemorrhoids with bleeding in Canada if Preparation H (phenylephrine) with Bio-Dyne has not improved symptoms after use following every bowel movement?
What is the appropriate dosing for gabapentin (anticonvulsant) in an 89-year-old male patient with pruritus (itch)?
What is the recommended use and dosage of Verquvo (vericiguat) for patients with symptomatic chronic heart failure?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question